Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.

Jacobs MF1, Dust H1, Koeppe E1, Wong S2, Mulholland M3, Choi EY4, Appelman H4, Stoffel EM5.

Author information

1: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
2: Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
3: Department of Surgery, University of Michigan, Ann Arbor, Michigan.
4: Department of Pathology, University of Michigan, Ann Arbor, Michigan.
5: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: estoffel@med.umich.edu.

Abstract

BACKGROUND & AIMS:

Pathogenic germline variants in CDH1 are associated with risk for diffuse gastric cancer (DGC) and lobular breast cancer. The reported high incidence of DGC and limited sensitivity of endoscopy in detection have prompted recommendation for total prophylactic gastrectomy for carriers of pathogenic or likely pathogenic (PLP) germline variants of CDH1. Multigene panel tests have identified increasing numbers of carriers of PLP variants in CDH1 who lack a family history of DGC. We evaluated outcomes of endoscopic surveillance for carriers of PLP variants of CDH1 with and without family history of DGC.

METHODS:

Individuals from 13 families with germline PLP variants of CDH1 were evaluated at the Michigan Medicine Cancer Genetics Clinic from January 1998 through May 2018. Outcomes of esophagogastroduodenoscopy examinations, histopathology analyses, and surgery were compared between individuals with and without a family history of DGC.

RESULTS:

We identified 20 carriers of germline CDH1 PLP variants; they underwent endoscopic examinations and/or gastrectomy. None had abnormal findings visible during endoscopy. Signet ring cell carcinoma (SRCC) was detected in 12 of 20 subjects. All but 1 of the carcinomas were tiny and confined to the lamina propria, and 1 was transmural. Seven of 12 subjects who had SRCC reported no diagnoses of DGC in first-degree relatives and did not meet established criteria for CDH1 analysis based on a 3-generation family pedigree.

CONCLUSIONS:

More than half of individuals with germlines variants of CDH1 that are PLP had histopathologic evidence for DGC on endoscopy and/or gastrectomy. Family history of DGC and endoscopic findings therefore do not appear to be reliable determinants of risk of SRCC in individuals with genetic predisposition to DGC.

KEYWORDS:

Cadherin 1; Familial; Inherited; Stomach Cancer

PMID:: 30935944
DOI:: 10.1053/j.gastro.2019.03.047

[Indexed for MEDLINE]

Themesothelioma News

Sunday, August 11, 2019